Stay updated on Tisotumab Vedotin in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.

Latest updates to the Tisotumab Vedotin in Cervical Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and the funding/status notice as well as Revision: v3.4.1 were removed. These are site maintenance updates that do not alter the study details or data.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about a funding lapse and the NIH Clinical Center opening status has been added, and the site revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check28 days agoChange DetectedUI and metadata updates: a glossary toggle is now shown, and QC/FEAR Act data labels have been added or adjusted. The document revision tag has been updated to v3.4.0.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. There are no changes to study content, eligibility criteria, or data.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a comprehensive Locations section listing site locations (Alabama, Arizona, California, Florida, Georgia, Indiana, Kentucky, Massachusetts, Nevada, New Jersey, New Mexico, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Wisconsin) and updated page revision to v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedThe page shows Revision: v3.3.2 replacing v3.3.1; no substantive content changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.